Meredith McKean, MD

Meredith McKean, M.D., MPH, is a board-certified medical oncologist and the director of Melanoma and Skin Cancer Research for Sarah Cannon Research Institute. She specializes in skin cancer treatment and research in addition to phase 1 drug development.

In her role at Sarah Cannon, Dr. McKean oversees investigational therapy trials for melanoma and other skin cancers. In 2017, she earned an ASCO Conquer Cancer Foundation Young Investigator Award, and in 2018, she received the MD Ande

Oncology care has become increasingly personalized, and I love to educate my patients on the best treatment options specifically for them. Patients are very knowledgeable and have often investigated different treatment options that might be available. I love my role helping patients become even more informed and make the best decisions for themselves and their families.